FDA Approved: SAXAGLIPTIN — Original Application (Glenmark Pharmaceuticals Inc., USA)

View source ↗

Summary

The FDA approved Glenmark's original Abbreviated New Drug Application for saxagliptin (generic) to treat type 2 diabetes mellitus.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Saxagliptin (saxagliptin)

Snippet

ORIG AP for SAXAGLIPTIN (SAXAGLIPTIN)